Skip to main content
logo
MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
68.57
+1.49 (2.22%)
Aug 14, 2026, 4:00 PM EDT - Market closed

MBX Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
3,3021,416616--
Market Cap Growth
659.09%129.95%---
Enterprise Value
2,8871,025339--
Last Close Price
68.5731.5418.43--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
8.033.842.39--
P/TBV Ratio
8.063.842.39--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.010.000.000.000.01
Net Debt / Equity Ratio
-1.01-1.01-1.02-1.01-1.02
Net Debt / EBITDA Ratio
3.533.823.862.291.67
Net Debt / FCF Ratio
4.874.564.722.501.78
Quick Ratio
17.8224.2623.7820.6012.42
Current Ratio
18.0824.6224.1921.2612.89
Return on Equity (ROE)
-33.17%-27.76%-36.71%-53.75%-
Return on Assets (ROA)
-22.08%-18.75%-24.17%-34.14%-
Return on Capital Employed (ROCE)
-28.60%-26.50%-26.50%-44.00%-60.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-3.16%-6.14%-10.05%--
FCF Yield
-2.58%-5.78%-9.02%--
Buyback Yield / Dilution
-62.14%-243.01%-944.70%-52.73%-
SEC Filings: 10-K · 10-Q